In addition, TSC1 overexpression resulted in poor outcomes in liver cancer patients (p < 0.05), but DCAF7 and EPS15 might not be associated with poor outcomes in liver cancer patients (both p > 0.05; Additional file 4: Fig. S4b) [23, 30]. Here, TSC1 is linked to liver cancer.